BSE Live
Oct 14, 16:00Prev. Close
197.60
Open Price
197.60
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 14, 15:59Prev. Close
197.58
Open Price
197.58
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
192.26 (3957)
Key Financial Ratios of Piramal Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 0.69 | 0.14 | -1.57 | 3.19 | 18.56 | |
Diluted EPS (Rs.) | 0.68 | 0.14 | -1.57 | 3.19 | 18.56 | |
Cash EPS (Rs.) | 6.30 | 5.28 | 3.65 | 7.62 | 13.40 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 61.35 | 59.80 | 56.76 | 56.47 | 56.35 | |
Book Value [InclRevalReserve]/Share (Rs.) | 61.35 | 59.80 | 56.76 | 56.47 | 56.35 | |
Revenue from Operations/Share (Rs.) | 69.10 | 61.76 | 59.34 | 55.31 | 63.49 | |
PBDIT/Share (Rs.) | 11.93 | 10.37 | 7.15 | 10.33 | 16.01 | |
PBIT/Share (Rs.) | 5.76 | 4.77 | 1.48 | 5.39 | 10.53 | |
PBT/Share (Rs.) | 2.58 | 0.91 | -1.46 | 3.59 | 9.07 | |
Net Profit/Share (Rs.) | 0.14 | -0.31 | -2.02 | 2.67 | 7.92 | |
NP After MI And SOA / Share (Rs.) | 0.69 | 0.13 | -1.56 | 3.17 | 8.40 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 17.26 | 16.78 | 12.05 | 18.68 | 25.21 | |
PBIT Margin (%) | 8.34 | 7.72 | 2.49 | 9.74 | 16.58 | |
PBT Margin (%) | 3.73 | 1.46 | -2.46 | 6.49 | 14.28 | |
Net Profit Margin (%) | 0.19 | -0.50 | -3.40 | 4.83 | 12.47 | |
NP After MI And SOA Margin (%) | 0.99 | 0.21 | -2.63 | 5.73 | 13.22 | |
Return on Networth/Equity (%) | 1.12 | 0.22 | -2.75 | 5.61 | 14.89 | |
Return on Capital Employed (%) | 6.40 | 5.76 | 1.65 | 6.54 | 12.45 | |
Return on Assets (%) | 0.58 | 0.11 | -1.28 | 2.93 | 7.66 | |
Total Debt/Equity (X) | 0.58 | 0.58 | 0.81 | 0.60 | 0.48 | |
Asset Turnover Ratio (%) | 0.59 | 0.55 | 0.33 | 0.34 | 0.00 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 1.54 | 1.25 | 1.26 | 1.34 | 1.47 | |
Quick Ratio (X) | 0.93 | 0.75 | 0.82 | 0.88 | 0.97 | |
Inventory Turnover Ratio (X) | 0.92 | 1.02 | 1.06 | 1.17 | 0.00 | |
Dividend Payout Ratio (NP) (%) | 15.87 | 0.00 | 0.00 | 0.00 | 0.00 | |
Dividend Payout Ratio (CP) (%) | 1.59 | 0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Retention Ratio (%) | 84.13 | 0.00 | 0.00 | 0.00 | 0.00 | |
Cash Earnings Retention Ratio (%) | 98.41 | 0.00 | 0.00 | 0.00 | 0.00 | |
Coverage Ratios | ||||||
Interest Coverage Ratios (%) | 3.75 | 3.06 | 2.48 | 6.18 | 9.74 | |
Interest Coverage Ratios (Post Tax) (%) | 3.75 | 3.06 | 2.48 | 6.18 | 9.74 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 33,950.47 | 21,129.13 | 13,363.10 | 0.00 | 0.00 | |
EV/Net Operating Revenue (X) | 3.71 | 2.59 | 1.89 | 0.00 | 0.00 | |
EV/EBITDA (X) | 21.49 | 15.40 | 15.66 | 0.00 | 0.00 | |
MarketCap/Net Operating Revenue (X) | 3.25 | 2.09 | 1.15 | 0.00 | 0.00 | |
Retention Ratios (%) | 84.12 | 0.00 | 0.00 | 0.00 | 0.00 | |
Price/BV (X) | 3.66 | 2.16 | 1.21 | 0.00 | 0.00 | |
Price/Net Operating Revenue | 3.25 | 2.09 | 1.15 | 0.00 | 0.00 | |
Earnings Yield | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 |
31.07.2025
30.07.2025
29.07.2025
Piramal Pharma Consolidated June 2025 Net Sales at Rs 1,933.71 crore, down 0.89% Y-o-Y
14.07.2025
29.07.2025
Piramal Pharma Consolidated June 2025 Net Sales at Rs 1,933.71 crore, down 0.89% Y-o-Y
19.05.2025
Piramal Pharma Standalone March 2025 Net Sales at Rs 1,689.80 crore, up 10.78% Y-o-Y
14.05.2025
Piramal Pharma Standalone March 2025 Net Sales at Rs 1,689.80 crore, up 10.78% Y-o-Y
14.05.2025
Piramal Pharma Consolidated March 2025 Net Sales at Rs 2,754.07 crore, up 7.9% Y-o-Y